Translational Development Acquisition Corp.

TDAC | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.87

+$0.02 (+0.18%)

At close: Sep 21, 2026, 4:00 PM ET

$10.87

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.18%

(1D)

Rating

Updated: Aug 20, 2026

19.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $267.73M

1D Range

10.85 10.89

52W Range

10.34 10.95

Valuation (TTM)

PE 41.81

PB 1.79

EV/EBITDA -203.87

Valuation (NTM)

Forward PE N/A

Forward PEG -1.07

Price Target N/A

Cash Flow

FCF Yield -0.3%

SBC Adj. FCF Yield -0.3%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y 0.0% | N/A

Dil EPS 3Y | 5Y 100.0% | N/A

FCF 3Y | 5Y -60.6% | N/A

Returns

ROA 3.5%

ROE 3.3%

ROIC -0.8%

Financial Health

Net Debt

$1.01M

Current Ratio 0.06

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business ...

Sector Financial Services

Industry Shell Companies

Employees 2

IPO Date Feb 19, 2025

Website www.translational-development.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.